Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-22

Clinical Trial Update: Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children [Phase 4]

View source ↗

Summary

This report summarizes a Phase 4 trial evaluating the effects of Concerta (methylphenidate) and Strattera (atomoxetine) on executive function in children with A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)
  • STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Peking University | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED